Avita Medical | 1811094D - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Accuray USD 41.89M 7.42M 2024-12
Celltrion KRW 50.61B 11.32B 2026-06
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 856.8M 430M 2025-12
CSL USD 4.46B 2.71B 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Mayne Pharma AUD 86.13M 18.92M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Nanosonics AUD 78.01M 3.95M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pacific Edge NZD 5.2M 1.75M 2024-06
Pharma Mar EUR 44.87M 5.63M 2026-06
Polynovo AUD 61.26M 38M 2025-12
PYC Therapeutics AUD 5.83M 750K 2025-06
Qiagen NV USD 340.39M 30.78M 2026-06
Ramsay Health Care AUD 549.95M 5.77B 2025-06
ResMed USD 890.98M 4.45M 2026-03
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Telix Pharmaceuticals AUD 260.35M 42.53M 2026-06
Tilray USD 57.47M 10.16M 2025-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03